Butterfly Network, Inc.

NYSE:BFLY

Medical - Devices

Healthcare
$6.08 +32.84%

+$1.88 today

Market cap
$1.63B
Beta
2.20
P/E (TTM)
-25.7
EPS (TTM)
-$0.30
52W Low $1.32High $8.01

Volume 4.78M

Average 4.92M

BFLY Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Butterfly Network, Inc.NYSE: BFLY

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue grows, but more slowly than its trailing trend

Q1 FY2026 cost of revenue of $8.25M rose 5.1% year over year, behind the +55.2% change in trailing-twelve-month cost of revenue. Sequentially, it fell 19.9% from the prior quarter. Over 3 fiscal years it compounded at +15.2% a year.

Context

  • Cost of revenue amounted to 53.1% of revenue in FY2025, up 12.7 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +5.1% toward the trailing-twelve-month pace of +55.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.25M-19.9% QoQ
Last fiscal yearDec 2025
$51.88M+56.1% YoY
LTMMar 2026
$52.28M+55.2% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.1%——
1 year+56.1%——
3-year CAGR+15.2%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
51.88M USD
Year-over-year change
+56.1%
4-year CAGR
+3.3%

Cost of Revenue vs competitors

How BFLY compares with its peers on the latest reported figures

  • Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +55.2% is the highest of 9, against a peer median of +10.3%.
  • Cost of revenue amounts to 50.8% of revenue for BFLY, versus a peer median of 62.1%.
BFLY Competitors
Cost of Revenue for BFLY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMNAMN Healthcare Services, Inc.LTM Mar 2026$2.47B USD+21.6%-17.8%72.4%
EVHEvolent Health, Inc.LTM Mar 2026$1.62B USD-20.2%+15.4%85.9%
OFIXOrthofix Medical Inc.LTM Mar 2026$255.74M USD-3.2%+29.9%31.0%
FLGTFulgent Genetics, Inc.LTM Mar 2026$196.33M USD+9.7%-8.7%61.3%
VALNValneva SELTM Mar 2026€110.28M EUR+10.9%-30.9%70.5%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$100.69M USD-21.2%+11.3%62.9%
BFLYButterfly Network, Inc.LTM Mar 2026$52.28M USD+55.2%+15.2%50.8%
SIBNSI-BONE, Inc.LTM Mar 2026$42.1M USD+14.9%+37.7%20.4%
ARVNArvinas, Inc.LTM Mar 2026$2.3M USD+35.3%—2.6%
Peer median (excluding BFLY) —+10.3%+11.3%62.1%

Competitors are the stored peer set for BFLY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue62.57M73.39M65.9M82.06M97.61M
Cost of Revenue45.51M33.93M49.04M33.23M51.88M
Gross Profit17.05M39.46M16.86M48.83M45.73M
Gross Margin27.3%53.8%25.6%59.5%46.9%
Research & Development74.46M88.04M55.62M37.8M36.26M
Selling, General & Admin135.32M144.44M106.85M85.44M85.11M
Operating Expenses209.78M232.48M162.47M123.24M132.15M
Depreciation & Amortization2.09M5.94M10.57M10.34M8.08M
EBITDA(29.55M)(162.74M)(123.04M)(60.92M)(67.38M)
EBITDA Margin-47.2%-221.8%-186.7%-74.2%-69.0%
Operating Income(192.73M)(193.02M)(145.61M)(74.41M)(86.42M)
Operating Margin-308.0%-263.0%-221.0%-90.7%-88.5%
Interest Income2.57M3.38M7.45M5.02M5.91M
Interest Expense651K2K01.26M1.49M
Other Income / Expenses160.44M24.34M11.99M1.89M9.46M
Income Before Tax(32.29M)(168.68M)(133.62M)(72.52M)(76.95M)
Pre-Tax Margin-51.6%-229.8%-202.8%-88.4%-78.8%
Income Tax Expense121K42K82K(32K)110K
Net Income(32.41M)(168.72M)(133.7M)(72.49M)(77.06M)
Net Margin-51.8%-229.9%-202.9%-88.3%-79.0%
EPS (Basic)(0.19)(0.84)(0.65)(0.34)(0.31)
EPS (Diluted)(0.19)(0.84)(0.65)(0.34)(0.31)
Weighted Avg Shares173.81M199.85M205.39M211.68M247.12M
Weighted Avg Shares (Diluted)173.81M199.85M205.39M211.68M247.12M

Butterfly Network, Inc.

NYSE:BFLY

Intrinsic Alpha fair value

Locked

Current Price

$6.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.